| Literature DB >> 34418622 |
Patrick M D'Aoust1, Syeda Tasneem Towhid1, Élisabeth Mercier1, Nada Hegazy1, Xin Tian1, Kamya Bhatnagar1, Zhihao Zhang1, Colleen C Naughton2, Alex E MacKenzie3, Tyson E Graber3, Robert Delatolla4.
Abstract
Wastewater-based epidemiology/wastewater surveillance has been a topic of significant interest over the last year due to its application in SARS-CoV-2 surveillance to track prevalence of COVID-19 in communities. Although SARS-CoV-2 surveillance has been applied in more than 50 countries to date, the application of this surveillance has been largely focused on relatively affluent urban and peri-urban communities. As such, there is a knowledge gap regarding the implementation of reliable wastewater surveillance in small and rural communities for the purpose of tracking rates of incidence of COVID-19 and other pathogens or biomarkers. This study examines the relationships existing between SARS-CoV-2 viral signal from wastewater samples harvested from an upstream pumping station and from an access port at a downstream wastewater treatment lagoon with the community's COVID-19 rate of incidence (measured as percent test positivity) in a small, rural community in Canada. Real-time quantitative polymerase chain reaction (RT-qPCR) targeting the N1 and N2 genes of SARS-CoV-2 demonstrate that all 24-h composite samples harvested from the pumping station over a period of 5.5 weeks had strong viral signal, while all samples 24-h composite samples harvested from the lagoon over the same period were below the limit of quantification. RNA concentrations and integrity of samples harvested from the lagoon were both lower and more variable than from samples from the upstream pumping station collected on the same date, indicating a higher overall stability of SARS-CoV-2 RNA upstream of the lagoon. Additionally, measurements of PMMoV signal in wastewater allowed normalizing SARS-CoV-2 viral signal for fecal matter content, permitting the detection of actual changes in community prevalence with a high level of granularity. As a result, in sewered small and rural communities or low-income regions operating wastewater lagoons, samples for wastewater surveillance should be harvested from pumping stations or the sewershed as opposed to lagoons.Entities:
Keywords: COVID-19; Pepper mild mottle virus; SARS-CoV-2; Wastewater surveillance; Wastewater treatment lagoon; Wastewater-based epidemiology
Mesh:
Substances:
Year: 2021 PMID: 34418622 PMCID: PMC8360995 DOI: 10.1016/j.scitotenv.2021.149618
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 7.963
Fig. 1Sampling locations and configurations: a) geographic locations of pumping station and lagoon, b) lagoon treatment system consisting of three cells, identification of sampling point, c) automatic sampler at pumping station, sampler dispenses samples into refrigerator, and d) automatic sampler under the solar panel at lagoon sampling point and sampling point.
Yearly average wastewater characteristics at the pumping station and lagoon effluent.
| Yearly average pumping station wastewater characteristics (avg. ± standard dev.) | Yearly average pumping lagoon wastewater characteristics (avg. ± standard dev.) | |
|---|---|---|
| cBOD5 (mg/L) | 88.4 ± 80.3 | 3.5 ± 0.9 |
| Total suspended solids (mg/L) | 224.3 ± 154.1 | 11.4 ± 6.1 |
| Total phosphorus (mg P/L) | 8.0 ± 5.6 | 0.2 ± 0.1 |
| Total ammonia nitrogen (mg N/L) | 34.2 ± 10.5 | 1.1 ± 1.1 |
| Total Kjeldahl nitrogen (mg N/L) | 49.0 ± 20.9 | 2.9 ± 2.2 |
| Alkalinity (mg/L as CaCO3) | 356.2 ± 60.4 | 126.2 ± 34.0 |
Fig. 2Comparison of genomic copies/L of pumping station samples and waste stabilization pond samples over time for the N1 and N2 SARS-CoV-2 gene regions, and PMMoV. Bars with a star (*) indicate that the sample signal was below the ALOQ.
Fig. 3Electropherograms of samples from the a) pumping station and the b) lagoon, showing drastic differences in the RNA profiles.
Fig. 4Average SARS-CoV-2 signal in the pumping station wastewater samples expressed as a) PMMoV normalized SARS-CoV-2 viral genomic copies, b) SARS-CoV-2 viral copies/g and c) SARS-CoV-2 viral genomic copies/L, along with the weekly COVID-19 test percent positivity.